Who makes CP- 690,550 and Tacrolimus?

CP- 690,550 and Tacrolimus is developed by Pfizer.

What development phase is CP- 690,550 and Tacrolimus in?

CP- 690,550 and Tacrolimus is in Phase 1.

Last reviewed 2026-05-15 · How we verify

CP- 690,550 and Tacrolimus

Pfizer · Phase 1 active Small molecule

At a glance

Generic name	CP- 690,550 and Tacrolimus
Sponsor	Pfizer
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CP- 690,550 and Tacrolimus CI brief — competitive landscape report
CP- 690,550 and Tacrolimus updates RSS · CI watch RSS
Pfizer portfolio CI